Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic…More diseases.
Social Media Links
REPORT RATINGS
4.8 / 5.0 (147)
Amicus Therapeutics, Inc. reports have an aggregate usefulness score of 4.8 based on 147 reviews.